226 related articles for article (PubMed ID: 32605309)
1. Identification of Differentially Methylated CpG Sites in Fibroblasts from Keloid Scars.
Alghamdi MA; Wallace HJ; Melton PE; Moses EK; Stevenson A; Al-Eitan LN; Rea S; Duke JM; Danielsen PL; Prêle CM; Wood FM; Fear MW
Biomedicines; 2020 Jun; 8(7):. PubMed ID: 32605309
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Scan for Methylation Profiles in Keloids.
Jones LR; Young W; Divine G; Datta I; Chen KM; Ozog D; Worsham MJ
Dis Markers; 2015; 2015():943176. PubMed ID: 26074660
[TBL] [Abstract][Full Text] [Related]
3. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of genome-wide DNA methylation profiles in keloids.
Jones LR; Greene J; Chen KM; Divine G; Chitale D; Shah V; Datta I; Worsham MJ
Laryngoscope; 2017 Jan; 127(1):70-78. PubMed ID: 27312686
[TBL] [Abstract][Full Text] [Related]
5. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
6. Causal network analysis of head and neck keloid tissue identifies potential master regulators.
Garcia-Rodriguez L; Jones L; Chen KM; Datta I; Divine G; Worsham MJ
Laryngoscope; 2016 Oct; 126(10):E319-24. PubMed ID: 26990118
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.
Altorok N; Tsou PS; Coit P; Khanna D; Sawalha AH
Ann Rheum Dis; 2015 Aug; 74(8):1612-20. PubMed ID: 24812288
[TBL] [Abstract][Full Text] [Related]
9. Keloid research: current status and future directions.
Tsai CH; Ogawa R
Scars Burn Heal; 2019; 5():2059513119868659. PubMed ID: 31452957
[TBL] [Abstract][Full Text] [Related]
10. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs.
Li C; Bai Y; Liu H; Zuo X; Yao H; Xu Y; Cao M
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):692-9. PubMed ID: 23709205
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
[TBL] [Abstract][Full Text] [Related]
13. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modification mechanisms involved in keloid: current status and prospect.
Lv W; Ren Y; Hou K; Hu W; Yi Y; Xiong M; Wu M; Wu Y; Zhang Q
Clin Epigenetics; 2020 Nov; 12(1):183. PubMed ID: 33243301
[TBL] [Abstract][Full Text] [Related]
15. From genetics to epigenetics: new insights into keloid scarring.
He Y; Deng Z; Alghamdi M; Lu L; Fear MW; He L
Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 28054407
[TBL] [Abstract][Full Text] [Related]
16. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
[TBL] [Abstract][Full Text] [Related]
17. Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids.
Liu J; Zhu H; Wang H; Li J; Han F; Liu Y; Zhang W; He T; Li N; Zheng Z; Hu D
J Mol Histol; 2018 Apr; 49(2):185-193. PubMed ID: 29455276
[TBL] [Abstract][Full Text] [Related]
18. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
20. Gene expression patterns in isolated keloid fibroblasts.
Satish L; Lyons-Weiler J; Hebda PA; Wells A
Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
